This peer-reviewed oral pathology article summarizes clinical evidence from Oral oncology (2026). It focuses on findings that may help dental professionals evaluate treatment decisions, patient outcomes, or clinical protocols.
Abstract
This review aims to evaluate the efficacy of vitamin E in the treatment of oral mucositis (OM). This review was conducted in accordance with Reporting Items for Systematic Reviews and Meta-analyses and registered in the International Prospective Register of Systematic Reviews (PROSPERO). The search was conducted in seven databases and in the Brazilian repository of Theses and Dissertations of CAPES, consulted as a complementary source identifying clinical trials that evaluated the use of vitamin E alone in cancer patients for the treatment of OM. The risk of bias was assessed using the Joanna Briggs Institute tool. The data were extracted and systematized in a meta-analysis using a fixed-effect model in RStudio software. Fourteen articles were included, which evaluated 715 patients, with 330 patients in the intervention group and 385 in the control group. Among the included studies, 64.3% (n = 9) showed a significant reduction in the incidence of severe OM with the use of vitamin E (p < 0.05). The risk of bias assessment indicated low methodological risk, with 65% (n = 9) classified as low overall risk. The meta-analysis showed a lower incidence of severe mucositis (grades 3-4) in the vitamin E group compared to controls (RR: 0.37; 95% CI: 0.25-0.57), with a consistent effect in pediatric (RR: 0.14; 95% CI: 0.05-0.35) and non-pediatric (RR: 0.57; 95% CI: 0.35-0.92) populations. The results suggest a potential benefit of vitamin E in the management of OM induced by antineoplastic therapies, especially in reducing the incidence of more severe forms of this condition.
Key takeaway
Key takeaway: This review-level evidence helps clinicians interpret the consistency and strength of available clinical findings in this topic area.
Peer-reviewed source
Deysimara de Cássia Santos, Larissa Torres Fernandes, Danielle Negri Ferreira Neves, Sibele Nascimento de Aquino, Gisele Queiroz Carvalho
Oral oncology. 2026
DOI: 10.1016/j.oraloncology.2026.107945
PMID: 41886966
PubMed: https://pubmed.ncbi.nlm.nih.gov/41886966/
Image: Caroline LM (Unsplash)
Oral pathology 06 July 2026
This peer-reviewed oral pathology article summarizes clinical evidence from Oral oncology (2026). It focuses on findings that may help dental professionals evaluate treatment decisions, patient...
Oral pathology 02 July 2026
This peer-reviewed oral pathology article summarizes clinical evidence from BMC oral health (2024). It focuses on findings that may help dental professionals evaluate treatment decisions, patient...
Oral pathology 29 June 2026
This peer-reviewed oral pathology article summarizes clinical evidence from Oral oncology (2026). It focuses on findings that may help dental professionals evaluate treatment decisions, patient...
Oral pathology 19 June 2026
This peer-reviewed oral pathology article summarizes clinical evidence from BMC oral health (2024). It focuses on findings that may help dental professionals evaluate treatment decisions, patient...
Oral pathology 10 June 2026
This peer-reviewed oral pathology article summarizes clinical evidence from BMC oral health (2024). It focuses on findings that may help dental professionals evaluate treatment decisions, patient...
Aligners F22® is an Edra professional dentistry reference focused on clinical practice, education and treatment planning.
Products 10 July 2026
Planmeca introduces two dental units designed to support modern clinical workflows through different concepts and use cases.
News 10 July 2026
BIOLASE, a MegaGen company and global leader in dental laser technology, today announced a significant investment in its Corona, California, manufacturing operations, underscoring
News 10 July 2026
Led by Farhad Boltchi, DMD, and Darin Dichter, DMD, the program provides a real-time look at the clinical decisions that shape anterior implant outcomes
Editorials 10 July 2026
From California to Canada: CU Anschutz School of Dental Medicine at ADEA, GRC and IADR 2026
The CU Anschutz School of Dental Medicine will showcase a wide breadth of educational innovation, faculty development, clinical training and research at three major gatherings this